Made for Next to Nothing. Worn by You?

Image Inside the house of an Indian family. A new report from the University of California, Berkeley, focuses on the exploited home workers who help make the country the world’s second largest manufacturer and exporter of fashion garments.CreditFredo de Luna/VW Pics — UIG, via Getty Images Ever since the Rana Plaza disaster in 2013, Western…

Details

Medical News Today: Immunosuppressants reduce artery plaque in people with psoriasis

New research finds that treatment with biologic drugs reduces coronary plaque buildup among people with severe psoriasis. An immunosuppressant drug for psoriasis can also improve heart artery health for those with the skin condition. Psoriasis is a chronic, inflammatory skin condition that affects 7.5 million people in the United States and approximately 125 million worldwide.…

Details

Intense IV blood sugar control doesn’t improve stroke outcomes

HONOLULU, Feb. 6, 2019 — Intravenous (IV) insulin did not improve stroke outcomes compared to standard blood sugar (glucose) control using insulin shots — answering a worldwide debate about the best way to control glucose in stroke patients. These primary late-breaking findings were presented at the American Stroke Association’s International Stroke Conference 2019, a world…

Details

Ambulance nitroglycerin patch to lower blood pressure did not improve stroke outcomes

HONOLULU, Feb. 6, 2019 — Lowering blood pressure in the ambulance with a nitroglycerin patch for suspected stroke didn’t lessen post-stroke disability, according to late breaking science presented at the American Stroke Association’s International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease. Two…

Details

Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke

HONOLULU, Feb. 6, 2019 — Stroke survivors taking a combination of the blood thinner cilostazol with aspirin or clopidogrel had a lower risk of ischemic stroke recurrence than those who received aspirin or clopidogrel alone, according to late breaking science presented at the American Stroke Association’s International Stroke Conference 2019, a world premier meeting for…

Details

Microbial manufacturing

For decades, scientists and doctors have known that bacteria in soil were capable of manufacturing streptozotocin, an antibiotic compound that is also an important treatment for certain types of pancreatic cancer. What was less clear, however, was exactly how bacteria managed to do it. Led by Emily Balskus, Professor of Chemistry and Chemical Biology, a…

Details

Certain characteristics linked with depression before and after giving birth

Depression during pregnancy and following childbirth (perinatal depression) is a common and potentially severe condition. In a Journal of Neuroscience Research study, researchers examined subgroups of women followed from pregnancy to six months postpartum, for example comparing those with depression only after childbirth with those experiencing depression during pregnancy. Several characteristics were associated with depression…

Details

Are most patients with fibromyalgia misdiagnosed?

Recent studies have suggested that most people who have been diagnosed with fibromyalgia by physicians may not actually have the condition. A new Arthritis Care & Research study found that overall agreement between clinicians’ diagnosis of fibromyalgia and diagnosis by published criteria is only fair. For the study, 497 patients visiting a rheumatology clinic completed…

Details

Maternal depression and natural disaster-related stress may affect infants’ temperament

A new Infant Mental Health Journal study demonstrates that prenatal maternal depression has important consequences for infant temperament. Furthermore, the negative impact of prenatal maternal depression appeared to be magnified when pregnant women lived through Superstorm Sandy. The study analyzed data on 310 mother-child dyads, with 64 percent of women being pregnant prior to Sandy…

Details